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Objective: To assess prevalence, potential risk factors and population attributable risk 
percentage (PAR%) for diabetic retinopathy (DR) in the Indian state of Andhra Pradesh.
Methods: A population-based study, using a stratiﬁ  ed, random, cluster, systematic sampling 
strategy, was conducted in the state of Andhra Pradesh in India during 1996 and 2000. Partici-
pants from 94 clusters in one urban and three rural areas representative of the population of 
Andhra Pradesh, underwent a detailed interview and a comprehensive dilated ocular evaluation 
by trained professionals. DR was deﬁ  ned according to the international classiﬁ  cation and grad-
ing system. For subjects more than or equal to 30 years of age, we explored associations of DR 
with potential risk factors using bivariable and multivariable analyses. Population attributable 
risk percent was calculated using Levin’s formula.
Results: Diabetic retinopathy was present in 39 of 5586 subjects, an age-gender-area-adjusted 
prevalence of 0.72% (95% conﬁ  dence interval (CI): 0.49%–0.93%) among subjects aged  
30 years old, and 0.27% (95% CI: 0.17%–0.37%) for all ages. Most of the DR was either mild 
(51.3%) or moderate (35.9%) non-proliferative type; one subject (2.6%) had proliferative reti-
nopathy. Multivariable analysis showed that increasing age, adjusted odds ratio (OR); 4.04 (95% 
CI: 1.88–8.68), middle and upper socioeconomic status group (OR); 2.34 (95% CI: 1.16–4.73), 
hypertension (OR); 3.48 (95% CI: 1.50–8.11) and duration of diabetes  15 years (OR); 8.62 
(95% CI: 2.63–28.29) were signiﬁ  cantly associated with increasing risk of DR. The PAR % 
for hypertension was 50%; it was 10% for cigarette smokers.
Conclusions: Extrapolating the prevalence of diabetic retinopathy in our sample to the Indian 
population suggests that there may be an estimated 2.77 million people with DR, approximately 
0.07 million people with severe DR. As the population demographics change towards aging, 
this number is likely to increase further. Health care programs in India need to examine strate-
gies to prevent diabetes and DR, as well as create the infrastructure required to manage this 
condition.
Keywords: diabetic retinopathy, risk factors, population attributable risk percent, population 
based cross-sectional study, southern India
Introduction
Diabetic retinopathy (DR) is the leading cause of visual impairment in the Western 
world, particularly among persons of working age (Klein et al 1984b). India has the 
largest number of diabetics in the world and DR is becoming an important cause of 
visual impairment (Kumar 1998). According to the latest World Health Organization 
(WHO) report, India has 31.7 million diabetic subjects, and the number is expected 
to increase to a staggering 79.4 million by 2030 (King et al 1998). The potential for 
blindness and vision impairment among persons with diabetes is well recognized. 
Standard treatment modalities are available and if instituted early may prevent blindness 
or maintain sight. Several risk factors have been implicated for onset and progression 
of blindness among diabetics. A better understanding of the risk factors, especially 
the modiﬁ  able risk factors, may help plan better strategies addressing diabetes and Clinical Ophthalmology 2007:1(4) 476
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diabetic retinopathy care in India (Wild et al 2004). We 
report on some of the possible risk factors for DR and the 
estimated population attributable risk percentage (PAR) 
associated with these risk factors for DR in a representative 
sample of the population aged 30 years and older from a 
state of South India.
Methods
The details of the design of Andhra Pradesh Eye Disease 
Study (APEDS), conducted during 1996–2000, following 
the tenets of the Helsinki Declaration, have been described 
previously (Dandona et al 1997, 1998, 2001). Approval of 
the Ethics Committee of the Institute was obtained for the 
study design.
Study sample
A multistage sampling procedure was used to select the study 
sample of 10,000 persons, 5000 each below and above 30 
years of age based on the assumption that a 0.5% preva-
lence of an eye disease in either of these groups may be of 
public health signiﬁ  cance. This sample would estimate the 
prevalence as 0.3% to 0.8% at the 95% conﬁ  dence level. 
One urban and three rural areas from different parts of the 
southern Indian state of Andhra Pradesh were selected, with 
the aim of including approximately 2500 participants in each 
area, such that these would roughly reﬂ  ect the urban-rural 
and socioeconomic distribution of the population of this 
state. These four areas were located in Hyderabad (urban), 
West Godavari district (well off rural), and Adilabad and 
Mahabubnagar districts (poor rural).
For the urban (Hyderabad) component of APEDS the 
blocks (clusters) of Hyderabad were stratiﬁ  ed by socioeco-
nomic status and religion. The socioeconomic strata were: 
extreme lower (monthly per capita income in Rupees  
200 [$US 5.1]), lower (201–500), middle (501–2000) and 
upper (2000); the religion strata were Hindu and Muslim. 
After this stratification, 24 clusters were chosen using 
stratiﬁ  ed random sampling with equal probability of selec-
tion, such that the socioeconomic and religion distribution 
in the sample would be similar to that in the population. 
The selected clusters were mapped, and households were 
selected systematically using a sampling interval of three to 
ﬁ  ve to obtain a similar number of households in the various 
clusters. A total of 2954 subjects were sampled with the aim 
of achieving a recruitment rate of at least 85% to obtain a 
minimum sample of 2500.
From three rural areas from different parts of Andhra 
Pradesh, 70 rural clusters were selected with the aim of 
having a study sample representative of the socioeconomic 
distribution of the rural population of the state. These three 
rural areas were located in (1) West Godavari (well-off rural), 
(2) Adilabad, and (3) Mahabubnagar districts (poor rural). 
For these three rural segments, a total of 8832 subjects were 
sampled of which 7771 eligible participants were interviewed 
by trained ﬁ  eld investigators.
Interview
The sampled subjects were interviewed in detail by trained 
ﬁ  eld investigators using a structured questionnaire in a 
masked manner (Dandona et al 1997). Questions included 
systemic history about the diagnosis and treatment of dia-
betes and ocular history and information on risk factors of 
systemic diseases and personal habits such as smoking. The 
questionnaire was designed to collect data on current and 
prior status of cigarette, beedi, hookah (both are local vari-
ants of cigarette), and chutta (home-rolled cigar, prepared 
and used extensively in the state of AP) smoking. The ﬁ  rst 
question related to smoking was on the current status of 
smoking (yes/no). If the response was yes, the volunteer 
was asked how long he/she had been smoking (years) and 
current level (in terms of number per day for cigarettes/ 
beedies / chuttas; hours per day for the hookah) of smoking. 
Similar information was also obtained from prior smokers. 
The structured questionnaire also had questions about alco-
hol consumption to ascertain the information on duration, 
quantity and frequency of alcohol consumption. Hyperten-
sion was deemed to be present, if a subject had a history of 
high blood pressure diagnosed by a physician and/or current 
usage of anti hypertensive medications and/or a blood pres-
sure reading of  140/90 mm Hg. Diabetes was deemed to 
be present, if a subject had a history of diabetes or was on 
anti-diabetic medications. Subjects not providing a history 
of diabetes but with retinopathy presumably from diabetes 
were subjected to a random blood sugar test. If the random 
blood sugar was above 120 mg/dl, the subject underwent a 
fasting blood sugar estimation on a subsequent day after an 
overnight fast.
Ophthalmologic examination
Subjects were brought to a clinic specially set up for this 
study. Written informed consent was obtained from the sub-
jects before examination. The examination was performed by 
two ophthalmologists and two optometrists who had received 
special training in the procedures of this study. It included 
presenting and best corrected distance and near logMAR 
visual acuity, complete anterior segment slit-lamp examina-Clinical Ophthalmology 2007:1(4) 477
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tion, and dilatation of pupil unless contraindicated because 
of risk of angle closure. After dilatation, stereoscopic fundus 
examination was done at the slit lamp using a 78 D lens and 
with the indirect ophthalmoscope using 20 D lens.
Subjects who were physically debilitated and unable 
to come to the APEDS clinic were examined at home with 
portable equipment. Examination with 78 D lens and pho-
tography were not done at home.
Deﬁ  nition of diabetic retinopathy
To grade DR a slight modiﬁ  cation of a standard classiﬁ  cation 
system (Olk et al 1993) was done for simpliﬁ  cation. Diabetic 
retinopathy was classiﬁ  ed as follows:
•  Non-proliferative diabetic retinopathy (NPDR):
•  Mild NPDR – microaneurysms, hard exudates and intraret-
inal hemorrhages present in fewer than four quadrants;
•  Moderate NPDR – moderate intraretinal hemorrhages 
present in four quadrants;
•  Severe NPDR – if any of the following three were present: 
severe intraretinal hemorrhages in four quadrants, venous 
beading in two quadrants, obvious intraretinal microvas-
cular abnormalities (IRMA) in one quadrant;
•  Very severe NPDR – if more than one of the three features 
listed for severe NPDR were present;
•  Proliferative diabetic retinopathy (PDR) – if any of the 
following were present: neovascularisation of the retina or 
iris or angle, preretinal or vitreous hemorrhage, tractional 
retinal detachment.
Stereoscopic photographs of the macula and optic disc 
were obtained with a Zeiss fundus camera in subjects hav-
ing any evidence of DR. Photographs of all the standard 
photographic ﬁ  elds of the fundus (Moss et al 1989) were not 
taken, though the major ﬁ  ndings used to classify DR were 
photographed. The grading of DR was based on the clinical 
examination, with the photographs serving as documentation. 
The photographs were reviewed by another ophthalmologist 
in an unmasked manner (for diagnosis of diabetes) to check 
for any major discrepancies with the clinical grading.
Subjects with fundus ﬁ  ndings suggestive of DR who were 
not known diabetics had random blood glucose tested with 
ﬁ  nger stick and glucometer (Bayer). If this was 120 mg/dl 
(6.7 mmol/l), fasting blood glucose was tested on another 
day. If this was 120 mg/dl, the subject was considered to 
have diabetes (WHO 1980).
Data management
Data were initially documented on the APEDS data collection 
forms by the clinical examiners and the ﬁ  eld investigators 
(Dandona et al 1997). This data collection was modiﬁ  ed by 
the principal investigator and coinvestigator of the study 
and discussed with the clinical and ﬁ  eld teams at regular 
intervals. The data were entered in a FoxPro database at the 
study headquarters in Hyderabad, and consistency checks 
were performed for these data (Dandona et al 1997).
Statistical analysis
The prevalence of DR and other estimates in our sample 
were adjusted for the estimated age and gender distribution 
of the population in India for the year 2000 (http://www.
census.gov). The 95% conﬁ  dence intervals were calculated 
by assuming a Poisson distribution (Rosner 1986 p 404–8) 
for prevalence 1%, and normal approximation of binomial 
distribution for prevalence of 1% or more. Variables of inter-
est were ﬁ  rst tested for associations with DR in bivariable 
analysis using the Fishers exact test or Chi-square test as 
appropriate and multivariable logistic regression was used 
to ﬁ  nd potential risk factors after adjusting for potential 
confounders. Population attributable risk percentage for 
the individual factors identiﬁ  ed in the multivariable logistic 
regression model were calculated using Levin’s formula 
(Pearce 1989). The software SPSS version 14.0 for Windows 
(SPSS, Chicago, IL, USA) was used for statistical analysis. 
A two-tailed P-value of less than 0.05 was considered sta-
tistically signiﬁ  cant.
Results
Study population
A total of 2522 (85.4%) of 2954 eligible participants from 
urban Hyderabad and 7771 (88%) of 8832 eligible partici-
pants from three rural Andhra Pradesh participated in the 
study. The study population was representative of both the 
urban and rural population of the state as a whole. In this 
study the data were analyzed for those more than or equal 
to 30 years old (n = 5586). The age range of the urban resi-
dents was 30 to 102 years (46.7 ± 12.9; median 45 years); 
631 (45.1%) were men. The age range for rural residents 
was 30 to 95 years (47.8 ± 12.9; median 45 years) and 1964 
(46.9%) were men.
Prevalence of diabetes
A total of 201 subjects, all above or equal to 30 years old, self 
reported diabetes, an age-gender-area-adjusted prevalence of 
3.68% (95% conﬁ  dence interval (CI): 3.18–4.17) and 1.34% 
(95% CI: 1.11–1.56) in all age groups considered together. 
The mean age of persons with diabetes was 55.3  10.7 years Clinical Ophthalmology 2007:1(4) 478
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(median: 55 years; range 30–86 years) and was not signiﬁ  -
cantly different between urban and rural areas (p = 0.103). 
The prevalence of self reported diabetes was similar in males 
and females (52.2 and 47.8% respectively)  30 years old. 
Age at diagnosis was less than 30 years for only one subject. 
Medications for diabetes were being used by 152 (75.6%) 
persons with diabetes.
DR prevalence and potential risk factors
The overall age-gender-area-adjusted prevalence of DR 
was 0.72% (95% CI: 0.49%–0.93%) in participants aged 
 30 years; it was 0.27% (95% CI: 0.17%–0.37%) in all 
age groups considered together. Among 201 subjects with 
diabetes, 39 (19.4%; 95% CI: 13.9–24.9) had DR. The mean 
age of the subjects with DR was 55.3 ± 9.4 years, (median: 
56 years; range 31–70 years). DR was present in 68 eyes of 
39 participants. Of the 39 subjects with DR, 20 (51.3%) had 
mild NPDR, 14 (35.9%) moderate NPDR, 3 (7.7%) severe 
NPDR and one (2.6%) PDR. The classiﬁ  cation of DR was 
not mentioned for one subject. Nine subjects (25.7%) with 
DR were visually impaired as a consequence, but none 
were blind due to DR. Among persons with diabetes, the 
prevalence of DR did not vary substantially among gender, 
however, it was signiﬁ  cantly different between urban and 
rural residents (21.6% vs 10.5%; p = 0.045).
Table 1 reports the distribution of DR. Increasing age, 
socioeconomic status, and duration of diabetes were posi-
tively associated with increasing risk of DR (Table 1). The 
potential risk factors evaluated in the bivariable analysis were 
age, socioeconomic status, place of residence, duration of 
diabetes, hypertension, and smoking (Table 1). In a multi-
variable logistic regression model that adjusted for potential 
confounders, age  50 years was associated signiﬁ  cantly 
with higher odds of DR (Table 2). When age was entered in 
the logistic regression model as a covariate, for unit (a year) 
of increment of age, there were 1.01 (95% CI: 0.97–1.05; 
p = 0.859) odds ratio of increment of DR in this population. 
The odds of prevalence of DR were also signiﬁ  cantly higher in 
the urban residents, adjusted OR 6.07 (95% CI: 2.84–12.98); 
middle and upper socioeconomic group, adjusted OR 2.34 
(95% CI: 1.16–4.73) and in hypertensives, adjusted OR 3.48 
(95% CI: 1.50–8.11) (Table 2). Duration of diabetes  15 
years was also signiﬁ  cantly associated with increased risk of 
DR, adjusted OR 8.62 (95% CI: 2.63–28.29). After adjusting 
for potential confounders in a multivariable logistic regres-
sion model that used systolic and diastolic blood pressures 
as continuous variables, the odds of DR were 1.03 (95% CI: 
1.01–1.04; p = 0.001) for each unit increase in the systolic 
blood pressure, and 1.03 (95% CI: 1.01–1.05; p = 0.012) for 
each unit increase in the diastolic blood pressure. The odds 
for DR among cigarette and cigar smokers were higher than 
the “never smoker” reference group, but it was not statisti-
cally signiﬁ  cant (Table 2). The PAR % for hypertension was 
50% and was 10% for cigarette smokers. Table 3 shows the 
relation of duration of diabetes and diabetic retinopathy.
Discussion
Data from this population-based study demonstrated the 
expected association between increased duration of diabetes, 
age and DR. Urban residence, middle and upper socioeco-
nomic status, and high blood pressure were also signiﬁ  -
cantly associated with DR. Based on our results, high blood 
pressure, and possibly cigarette smoking were identiﬁ  ed as 
modiﬁ  able risk factors.
The age-gender-area-adjusted prevalence of DR in this 
population was 0.72% (95% CI: 0.5%–0.9%) in partici-
pants aged  30 years. Our prevalence estimate of diabetic 
retinopathy was similar to that of previously published 
reports (Klein et al 1991; Lundbaek 1995). Our prevalence 
estimate of all DR is slightly higher than the estimate of 
previously published report from a different state of south 
India (0.5%; 95% CI: 0.3%–0.7%) (Nirmalan et al 2004). 
However, our estimate of DR is less than that previously 
published reports from other populations (Lopez et al 2002; 
Tapp et al 2003; Giuffre et al 2004; Kempen et al 2004; 
Varma et al 2004).
Patients diagnosed with diabetes by their physicians may 
be at higher risk of having more severe retinopathy present at 
the time of their diagnosis (Klein et al 1984b). They would 
be more likely to beneﬁ  t from an immediate ophthalmologic 
examination. It is evident that many people with diabetes 
unaware that they may develop DR. Improved control of 
blood glucose levels, blood pressure, and serum lipid levels 
is likely to reduce the incidence, rate of progression, and/or 
severity of diabetic retinopathy. Improvements in the effec-
tiveness of primary diabetes care over time could reduce 
the incidence of diabetic retinopathy and its rate of progres-
sion. However, improved diabetes care also could result in 
improved survival. Unlike other age-related eye diseases, 
diabetic retinopathy often causes blindness during working 
age years resulting in a large number of person-years of vision 
loss and correspondingly large economic cost.
If we project the DR prevalence of 0.27% to the 1027 
million population in India, there could be 2.77 million 
people with DR inclusive of approximately 0.07 million 
people with severe DR, who would require deﬁ  nite treatment Clinical Ophthalmology 2007:1(4) 479
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for DR. Tackling this burden will need a larger pool of trained 
personnel besides adequate infrastructure support. Training 
to treat vitreoretinal diseases (either lasers or surgical inter-
ventions) including diabetic retinopathy is currently not part 
of all ophthalmology residency programs; such training is 
often offered as post-residency fellowships in India (Fong 
et al 2004). A larger proportion of the persons with diabetes 
currently have the less severe forms of retinopathy or no 
Table 1  Associations between prevalence of DR, demographic factors, smoking and hypertension in the study population
Characteristic Total  population  (n  = 5,586)  DR no (%)  P-value
Age
30–39   1863  1 (0.1)  0.0001†
40–49 1424  8  (0.6) 
50–59 1047  17  (1.6) 
60–69 899  10  (1.1) 
70+ 353  3  (0.8) 
Sex    
Male   2595  22 (0.8)  0.259§
Female 2991  17  (0.6) 
Socioeconomic status$ 
Extreme lower  645  3 (0.5)  0.0001†
Lower 2781  9  (0.3) 
Middle 1859  23  (1.2) 
Upper    215  4 (1.9) 
Place of residence 
Urban 1399  29  (2.1)  0.0001§
Rural 4187  10  (0.2) 
Diabetes 
Yes 205  39  (19.0)  0.0001§
No 5381  0  (0.0)
Duration of diabetes 
0–9 years  155  21 (13.5)  0.0001†
10–14 years  27  5 (18.5) 
15–19 years  12  7 (58.3) 
20 years  6  5 (83.3) 
Any smoking 
Yes 3700  29  (0.8)  0.313§
No 1885  10  (0.5) 
Beedi smoking 
Never a smoker  4577  35 (0.8)  0.218†
Current smoker  817  2 (0.2) 
Prior smoker  191  2 (1.0) 
Hooka smoking    
Never a smoker  5582  39 (0.7)  --
Current smoker   –  – 
Prior smoker  3  – 
Cigarette smoking    
Never a smoker  5121  32 (0.6)  0.0001†
Current smoker  310  1 (0.3) 
Prior smoker  154  6 (3.9) 
Cigar smoking    
Never a smoker  4975  36 (0.7)  0.312†
Current smoker  455  1 (0.2) 
Prior smoker  155  2 (1.3) 
Hypertension     0.0001§
No 3271  7  (0.2) 
Yes   2315  32 (1.4) 
Notes: †Chi-square test
§Fisher’s exact test.
$Socioeconomic status deﬁ  ned according to monthly per capita income in Indian rupees:  200 extreme lower; 201–500 lower; 501–2000 middle and 2000 upper. Data 
on socioeconomic status were not available for 86 subjects. 
Data on duration of diabetes were not available for one subject. Data on smoking were not available for one subject.Clinical Ophthalmology 2007:1(4) 480
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retinopathy. Preventing the conversion of such persons to 
more severe forms of retinopathy is very important. This 
needs a concerted effort by ophthalmologists and internists 
who are engaged in the primary care for diabetes.
We found with multivariable analysis that subjects 
belonging to the middle or upper socioeconomic strata had 
a 2.3 fold higher risk of having DR than those belonging 
to lower or extreme lower strata and it was statistically 
signiﬁ  cant (Table 2). One could speculate that this trend 
could be the result of less predisposition of the lower 
socioeconomic strata to DR or higher mortality at rela-
tively younger age or a combination of these two. Further 
Table 2 Bivariate and multivariable logistic regression analyses for associations between potential risk factors and DR (n = 5586)
Characteristic  Total   DR no (%)  Crude odds ratio   Adjusted odds   PAR‡
  population   (95%  CI)  ratio§ (95% CI)
Age$ 
30–49 3287  9  (0.3)  1.00  1.00 
 50  2299  30 (1.3)  4.81 (2.28–10.14)  4.04 (1.88–8.68)  --
Sex        
Male  2595  22 (0.8)  1.50 (0.79–2.82)  1.74 (0.83–3.67)  --
Female 2991  17  (0.6)  1.00  1.00 
Area        
Urban  1399  29 (2.1)  8.84 (4.30–18.19)  6.07 (2.84–12.98)  --
Rural 4187  10  (0.2)  1.00  1.00 
Socioeconomic status$ 
Extreme Lower  &    3426  12 (0.4)  1.00  1.00 
Lower        
Middle & Upper  2074  27 (1.3)  3.75 (1.90–7.42)  2.34 (1.16–4.73)  --
High BP        
No 3271  7  (0.2)  1.00  1.00 
Yes  2315  32 (1.4)  6.54 (2.88–14.83)  3.48 (1.50–8.11)  0.50 (0.17–0.74)
Duration of diabetes$        
0–9 years  155  21 (13.5)  1.00  1.00 
10–14 years  27  5 (18.5)  1.02 (0.32–3.23)  1.00 (0.25–2.65)  0.00
 15 years  18  12 (66.7)  9.21 (2.98–28.41)  8.62 (2.63–28.29)  0.02 (0.0–0.11)
Cigarette smoking§$        
Never a smoker  5122  32 (0.6)  1.00  1.00 
Ever smoker  463  7 (1.5)  2.44 (1.07–5.56)  1.10 (0.44–2.79)  0.10 (0.0–0.14)
Cigar smoking§$        
Never a smoker  4975  36 (0.7)  1.00  1.00 
Ever smoker  610  3 (0.5)  1.00 (0.21–2.35)  1.37 (0.36–5.14)  0.04 (0.0–0.33)
Notes: §Cigarette and cigar smoking variables were replaced in the multivariable logistic regression model. 
§Age adjusted odds ratios. 
‡PAR estimates were derived from multivariable logistic regression model and therefore are not additive. In the parentheses, 95% CIs.
$Categories for these variables were combined to increase the power of the analysis.
Socioeconomic status deﬁ  ned according to monthly per capita income in Indian rupees:  200 extreme lower; 201–500 lower; 501–2000 middle and 2000 upper. Data 
on socioeconomic status were not available for 86 subjects. Data on duration of diabetes were not available for one subject. Data on smoking were not available for one 
subject.
Table 3 Relation of duration since diagnosis of diabetes and DR (n = 200)
Duration since   Number   Number   Number   Number   Number 
diagnosis of diabetes  (%)  (%)  (%)  (%)  (%)
  without DR  mild NPDR  moderate   severe   PDR
     NPDR  NPDR 
0–9 years  134 (67.0)  12 (6.0)  9 (4.5)  0  0
10–14 years  22 (11.0)  1 (0.01)  2 (1.0)  1 (0.01)  1 (0.01)
15–19 years  5 (2.5)  5 (2.5)  1 (0.01)  1 (0.01)  0
20 years  1 (0.01)  2 (1.0)  2 (1.0)  1 (0.01)  0
Total  162 (81.0)  20 (10.0)  14 (7.0)  3 (1.5)  1 (0.01)
Notes: Data on duration of diabetes were not available for one subject. NPDR, non-proliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy. Clinical Ophthalmology 2007:1(4) 481
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study would be needed for veriﬁ  cation of this ﬁ  nding and 
its implications.
We found a statistically signiﬁ  cant association between 
hypertension and DR, which is in accordance with previ-
ously published reports (Klein 1989; Tapp et al 2003; Van 
Leiden 2003; Hove et al 2004; Leske et al 2005; Rema, 
Premkumar et al 2005; Wong et al 2006). Though a lot of 
studies have shown the association between hypertension 
and DR, the exact pathogenesis is not known. However, the 
available evidence supports the theory that (a) hemodynamic 
alternations in retinal microvasculature and (b) hypertension 
induced increased expression of vascular endothelial growth 
factor could be the probable mechanisms involved in the pro-
gression of DR. The pathogenesis of renal microangiopathy 
may be very similar to that of retinal microangiopathy, and 
both may be accelerated by high blood pressure. This study 
demonstrates that the blood pressure of persons with diabe-
tes should be monitored in addition to their glucose control. 
Population attributable risk (PAR) percentage for associated 
risk factors varied between 10%–50%. The prevalence of 
hypertension in this population seems high and may reﬂ  ect 
error in the diagnosis. If we take a conservative deﬁ  nition 
of hypertension (if a subject had a history of high blood 
pressure diagnosed by a physician and/or current usage of 
anti hypertensive medications), the prevalence decreases to 
9% and the PAR to 18%. The prevalence of hypertension in 
other studies has been reported to vary from 20% to 40% in 
urban adults and 12%–17% in rural residents (Gupta 2004). 
If we consider these prevalence estimates, the PAR% for 
hypertension in urban adults could be as low as 33% and as 
high as 50%. The PAR% for hypertension in rural residents 
could vary from 23% to 30%. Either way, the high PAR% 
for hypertension in this population is an additional reason 
for modifying this risk factor as a public health intervention. 
A PAR% of 10% for smoking provides another reason to 
encourage people to give up this habit.
The association of longer duration with a higher the risk 
of DR was in accordance with previously published reports 
(DCCT 1993; Klein et al 1995; Shriwas et al 1996; UKPDS 
1998a, 1998b; Larsson et al 1999; Tapp et al 2003; Giuffre 
et al 2004; Jenchitr et al 2004; Varma 2006; Wong et al 
2006). In the present study, the prevalence of DR was 19% 
among diabetes subjects, which is similar to that previously 
published report from a different state of southern India 
(Rema, Sujatha et al 2005). Changing demographics in India, 
shift towards aging, higher prevalence of diabetes, translates 
to a lot more persons with diabetes possibly living longer, 
thus more persons at risk for DR.
With the availability of the tools like the Diabetes Risk 
Score (Mohan et al 2005), it is possible to identify those at 
high risk of diabetes in the general population. Primordial 
preventive measures like weight control and lifestyle changes 
can prevent the progression of diabetes and its complications 
like DR. Maintaining a strict glycaemic control and regular 
ophthalmic examinations of those identiﬁ  ed as diabetic to 
detect early retinopathy are the ways to prevent blindness 
from retinopathy in people with diabetes (Narendran et al 
2002). Treatment modalities exist that can prevent or delay 
the onset of diabetic retinopathy, as well as prevent loss of 
vision, in a large proportion of patients with diabetes. Timely 
laser photocoagulation therapy can also prevent loss of vision 
in a large proportion of patients with severe NPDR and 
PDR and/or macular edema. Because a signiﬁ  cant number 
of patients with vision-threatening disease may not have 
symptoms, ongoing evaluation for retinopathy is a valuable 
and required strategy (Fong et al 2004). This is yet another 
reason to insist on a comprehensive eye exam, especially in 
a country where this is not always the norm.
The many strengths of this study include use of standard-
ized methods for collecting and grading of fundus photo-
graph, the representativeness of the study population, and the 
high response rate. A limitation of study is that all standard 
photographic ﬁ  elds of the stereo fundus photographs were 
not taken and graded by masked observer(s). Although the 
two ophthalmologists who graded DR clinically were trained 
specially for the study, it is possible that some misgrading of 
DR could have occurred. If any cases of DR were missed, 
however, these would have most likely been mild NPDR. 
The other limitations of our study include the ascertainment 
of diabetes by history, and the relatively few cases of DR. 
It is possible that we may have missed some important risk 
factors.
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